The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as potentially alleviate some of the drug's common side effects.

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

Just because Wall Street likes a stock doesn't mean it's a great pick. In some cases, they're so optimistic that their price ...

Oprah Winfrey said taking weight-loss drugs, like Ozempic and Wegovy, helped her realize the truth about 'thin people.' ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...